Cancer Biology & Therapy

Papers
(The TQCC of Cancer Biology & Therapy is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Target c-Myc to treat pancreatic cancer49
Exosomal taurine up-regulated 1 promotes angiogenesis and endothelial cell proliferation in cervical cancer33
Cancer-associated fibroblasts derived extracellular vesicles promote angiogenesis of colorectal adenocarcinoma cells through miR-135b-5p/FOXO1 axis30
Therapeutic enhancement of radiation and immunomodulation by gold nanoparticles in triple negative breast cancer28
Anti-tumor effect of trametinib in bladder cancer organoid and the underlying mechanism27
Long non-coding RNA (lncRNA) and epithelial-mesenchymal transition (EMT) in colorectal cancer: a systematic review26
ST8SIA6-AS1 promotes hepatocellular carcinoma by absorbing miR-5195-3p to regulate HOXB625
CXCL6 regulates cell permeability, proliferation, and apoptosis after ischemia–reperfusion injury by modulating Sirt3 expression via AKT/FOXO3a activation24
Dysregulated circRNA_100876 contributes to proliferation and metastasis of colorectal cancer by targeting microRNA-516b (miR-516b)23
LncRNA OIP5-AS1 promotes cell proliferation and migration and induces angiogenesis via regulating miR-3163/VEGFA in hepatocellular carcinoma22
Trojan horse treatment based on PEG-coated extracellular vesicles to deliver doxorubicin to melanoma in vitro and in vivo22
Interleukin-2, Ipilimumab, and Anti-PD-1: clinical management and the evolving role of immunotherapy for the treatment of patients with metastatic melanoma22
LncRNA AFAP1-AS1 modulates the sensitivity of paclitaxel-resistant prostate cancer cells to paclitaxel via miR-195-5p/FKBP1A axis22
Graphene quantum dots mediated magnetic chitosan drug delivery nanosystems for targeting synergistic photothermal-chemotherapy of hepatocellular carcinoma21
Tumor associated neutrophils promote the metastasis of pancreatic ductal adenocarcinoma21
Pan-cancer analysis of ARID family members as novel biomarkers for immune checkpoint inhibitor therapy19
The therapeutic potential of exosomal miR-22 for cervical cancer radiotherapy19
HMGA2 promotes breast cancer metastasis by modulating Hippo-YAP signaling pathway19
LINC00641/miR-4262/NRGN axis confines cell proliferation in glioma18
Chetomin, a Hsp90/HIF1α pathway inhibitor, effectively targets lung cancer stem cells and non-stem cells18
Heparan sulfate proteoglycans as targets for cancer therapy: a review17
CRC-derived exosomes containing the RNA binding protein HuR promote lung cell proliferation by stabilizing c-Myc mRNA17
YY1-inudced activation of lncRNA DUXAP8 promotes proliferation and suppresses apoptosis of triple negative breast cancer cells through upregulating SAPCD217
NEDD4L inhibits glycolysis and proliferation of cancer cells in oral squamous cell carcinoma by inducing ENO1 ubiquitination and degradation17
MiR-185-3p mimic promotes the chemosensitivity of CRC cells via AQP517
Desmoglein-2 as a prognostic and biomarker in ovarian cancer16
NSUN6, an RNA methyltransferase of 5-mC controls glioblastoma response to temozolomide (TMZ) via NELFB and RPS6KB2 interaction16
The role of CD133 in hepatocellular carcinoma16
Long non-coding RNA SLCO4A1-AS1 drives the progression of non-small-cell lung cancer by modulating miR-223-3p/IKKα/NF-κB signaling16
Crosstalk between PI3K/Akt and Wnt/β-catenin pathways promote colorectal cancer progression regardless of mutational status15
Curcumin activates NLRC4, AIM2, and IFI16 inflammasomes and induces pyroptosis by up-regulated ISG3 transcript factor in acute myeloid leukemia cell lines15
Biomarkers for early detection of pancreatic cancer – miRNAs as a potential diagnostic and therapeutic tool?15
Ovarian cancer: new strategies and emerging targets for the treatment of patients with advanced disease15
Feasibility and safety of targeting mitochondria for cancer therapy – preclinical characterization of gamitrinib, a first-in-class, mitochondriaL-targeted small molecule Hsp90 inhibitor14
FERMT1 promotes gastric cancer progression by activating the NF-κB pathway and predicts poor prognosis14
A novel targeted GPC3/CD3 bispecific antibody for the treatment hepatocellular carcinoma14
Inhibition of nucleophosmin 1 suppresses colorectal cancer tumor growth of patient -derived xenografts via activation of p53 and inhibition of AKT13
Lutetium-177-PSMA-617: A Vision of the Future13
The Anti-fibrosis drug Pirfenidone modifies the immunosuppressive tumor microenvironment and prevents the progression of renal cell carcinoma by inhibiting tumor autocrine TGF-β13
Expression and clinical implication of cyclooxygenase-2 and E-cadherin in oral squamous cell carcinomas13
Silencing the intestinal GUCY2C tumor suppressor axis requires APC loss of heterozygosity12
Long non-coding RNA ARAP1-AS1 promotes the proliferation and migration in cervical cancer through epigenetic regulation of DUSP512
Frequency of S492R mutations in the epidermal growth factor receptor: analysis of plasma DNA from patients with metastatic colorectal cancer treated with panitumumab or cetuximab monotherapy12
The role of extracellular DNA (exDNA) in cellular processes12
CYP2C8 regulated by GAS5/miR-382-3p exerts anti-cancerous properties in liver cancer12
TP53 mutation detected in circulating exosomal DNA is associated with prognosis of patients with hepatocellular carcinoma12
Integration of radiotherapy with anti-PD-1 antibody for the treatment of intrahepatic or hilar cholangiocarcinoma: reflection from four cases12
Selecting the optimal parameters for sonoporation of pancreatic cancer in a pre-clinical model12
BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes12
Current perspectives on exosomes in the diagnosis and treatment of hepatocellular carcinoma (review)11
Loading of ”cocktail siRNAs” into extracellular vesicles via TAT-DRBD peptide for the treatment of castration-resistant prostate cancer11
FGF13 interaction with SHCBP1 activates AKT-GSK3α/β signaling and promotes the proliferation of A549 cells11
Small extracellular vesicle-mediated ITGB6 siRNA delivery downregulates the αVβ6 integrin and inhibits adhesion and migration of recipient prostate cancer cells11
Circular RNA hsa_circ_0003204 promotes cervical cancer cell proliferation, migration, and invasion by regulating MAPK pathway11
Rac1 repression reverses chemoresistance by targeting tumor metabolism11
circ_C20orf11 enhances DDP resistance by inhibiting miR-527/YWHAZ through the promotion of extracellular vesicle-mediated macrophage M2 polarization in ovarian cancer11
LncRNA FGD5-AS1 accelerates cell proliferation in pancreatic cancer by regulating miR-520a-3p/KIAA1522 axis11
Partial treatment response to capmatinib in MET-amplified metastatic intrahepatic cholangiocarcinoma: case report & review of literature10
Carcinoma-associated fibroblasts release microRNA-331-3p containing extracellular vesicles to exacerbate the development of pancreatic cancer via the SCARA5-FAK axis10
Targeting long non-coding RNA PVT1/TGF-β/Smad by p53 prevents glioma progression10
Colorectal cancer chemoprevention: is aspirin still in the game?10
Requirement for containing etoposide in the initial treatment of lymphoma associated hemophagocytic lymphohistiocytosis10
Epigenetic modulation of FBW7/Mcl-1 pathway for lung cancer therapy10
Long non-coding RNA FALEC promotes colorectal cancer progression via regulating miR-2116-3p-targeted PIWIL110
Mechanically activated ion channel Piezo1 contributes to melanoma malignant progression through AKT/mTOR signaling10
miR-221-3p promotes hepatocellular carcinogenesis by downregulating O6-methylguanine-DNA methyltransferase10
Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy10
GANT61 suppresses cell survival, invasion and epithelial-mesenchymal transition through inactivating AKT/mTOR and JAK/STAT3 pathways in anaplastic thyroid carcinoma10
Expression of STAT1 is positively correlated with PD-L1 in human ovarian cancer10
LncRNA WWOX-AS1 sponges miR-20b-5p in hepatocellular carcinoma and represses its progression by upregulating WWOX10
The role of the ubiquitin-proteasome pathway in skin cancer development: 26S proteasome-activated NF-κB signal transduction9
MAP17 contributes to non-small cell lung cancer progression via suppressing miR-27a-3p expression and p38 signaling pathway9
The NF-κB/miR-488/ERBB2 axis modulates pancreatic cancer cell malignancy and tumor growth through cell cycle signaling9
Targeted drug delivery using an aptamer against shared tumor-specific peptide antigen of MAGE-A39
BMSC-derived exosomal lncRNA PTENP1 suppresses the malignant phenotypes of bladder cancer by upregulating SCARA5 expression9
The top 100 most-cited papers in long non-coding RNAs: a bibliometric study9
Obesity and metabolic syndrome related macrophage promotes PD-L1 expression in TNBC through IL6/JAK/STAT pathway and can be reversed by telmisartan9
STAT1 mediated long non-coding RNA LINC00504 influences radio-sensitivity of breast cancer via binding to TAF15 and stabilizing CPEB2 expression9
Clinicopathological features of PD-L1 protein expression, EBV positivity, and MSI status in patients with advanced gastric and esophagogastric junction adenocarcinoma in Japan9
MLLT11-TRIL complex promotes the progression of endometrial cancer through PI3K/AKT/mTOR signaling pathway9
LncRNA DUXAP8 induces breast cancer radioresistance by modulating the PI3K/AKT/mTOR pathway and the EZH2-E-cadherin/RHOB pathway9
LINC01128 resisted acute myeloid leukemia through regulating miR-4260/NR3C29
CAFs-derived small extracellular vesicles circN4BP2L2 promotes proliferation and metastasis of colorectal cancer via miR-664b-3p/HMGB3 pathway9
0.029507160186768